Multiple Myeloma and Amyloidosis Program

If you’ve been diagnosed with the rare diseases of multiple myeloma or amyloidosis, it’s important to be evaluated by hematology experts before beginning treatment. We can help.

Karmanos’ Multiple Myeloma and Amyloidosis Specialists

Our Multiple Myeloma and Amyloidosis Multidisciplinary Team sees between 230 and 250 new multiple myeloma patients and between 30 and 50 new amyloidosis patients each year. 

The team spans many disciplines, including hematologists, medical oncologists, specialized nurse practitioners, bone marrow transplant specialists, radiologists, pathologists, cardiologists, nephrologists, radiation oncologists, orthopedic surgeons, dietitians and social workers.  The team is entirely focused on treating multiple myeloma and amyloidosis and shares its collective expertise to create a customized treatment plan for each patient.

Our team of researchers not only has vast clinical expertise, but also years of clinical research experience. We have one of the largest myeloma bone marrow transplant programs in the country and are one of the few centers in the region offering investigational cellular therapies such as CAR-T cells to patients with Multiple Myeloma. 

In fact, Karmanos also has more active clinical trials for patients with multiple myeloma and amyloidosis than any other center in the state of Michigan. The team collaborates with basic scientists to better understand multiple myeloma and amyloidosis and to bring these new therapies to the clinic.

Evaluation & Diagnosis

Every new multiple myeloma or amyloidosis patient seen in consultation at Karmanos has his or her case reviewed in the weekly MDT meeting to facilitate a customized treatment plan and timely referral to the various subspecialists needed for optimal care. During your initial visit at a Karmanos location, a physician will review your medical records, medical history and review your x-rays and pathology slides.

Innovative, Individualized Care

Here’s what patients can expect from our Multiple Myeloma and Amyloidosis Multidisciplinary Team:

  • A passionate, caring, expert team, giving you the best chance of success.
  • A collaborative approach that considers all available treatment options, including clinical trials, for your specific type of cancer.
  • A carefully constructed treatment plan designed to achieve the best possible outcome.
  • Respectful, compassionate care that is responsive to your emotional needs and lifestyle.
  • Proactive, timely communication with you and your loved ones, and your personal physician.

Appointment Information

Request an Appointment Online Request an Appointment By Phone

The Latest From Karmanos Cancer Institute

News

IN THE NEWS: Detroit Cancer Center Unveils New Device for Treating Liver Cancer at Home

The Detroit News The TheraBionic P1 device is now available for patients who have advanced liver cancer and have failed first- and second-line the...

Read More

Karmanos Cancer Institute Physicians Begin Prescribing New FDA-approved Radiofrequency Electromagnetic Device to Treat Advanced Liver Cancer

The Barbara Ann Karmanos Cancer Institute , the largest provider of cancer care and research in Michigan and part of McLaren Health Care, announce...

Read More

CURE, in Collaboration with Karmanos' Office of Cancer Health Equity and Community Engagement, Educates the Community About Metastatic Breast Cancer

On Wednesday, Dec. 4, 2024, patients, survivors, and advocates gathered at Karmanos Cancer Institute in Detroit to learn about metastatic breast c...

Read More
News

WDET | Scholarship Program Aims to Encourage More Diversity in Clinical Trials

Listen Now

101 WRIF | Lung Cancer Awareness

Listen Now

Becker’s Healthcare Podcast | Exploring Breakthroughs in Cancer Treatment with Dr. Boris C. Pasche, President & CEO at Karmanos Cancer Institute

Listen Now